Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Young

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 11, 2012
IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J miceAndrew L Rankin, Heath Guay, Deborah Herber, et al.
Science Translational Medicine|December 21, 2012
Long-term follow-up after gene therapy for canavan diseasePaola Leone, David Shera, Scott W J McPhee, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Interleukin-21 receptor deficiency increases the initial toll-like receptor 2 response but protects against joint pathology by reducing Th1 and Th17 cells during streptococcal cell wall arthritisRenoud J Marijnissen, Debbie M Roeleveld, Deborah Young, et al.
Diabetes|October 21, 2011
IL-21 is an antitolerogenic cytokine of the late-phase alloimmune responseAlessandra Petrelli, Michele Carvello, Andrea Vergani, et al.
The Journal of Clinical Investigation|December 17, 2008
IL-21R is essential for epicutaneous sensitization and allergic skin inflammation in humans and miceHaoli Jin, Michiko K Oyoshi, Yi Le, et al.
Platelets|March 10, 2017
Inhibition of NMDA receptor function with an anti-GluN1-S2 antibody impairs human platelet function and thrombosisTaryn N Green, Justin R Hamilton, Marie-Christine Morel-Kopp, et al.
Journal of Clinical Epidemiology|March 4, 2019
The selection of comparators for randomized controlled trials of health-related behavioral interventions: recommendations of an NIH expert panelKenneth E Freedland, Abby C King, Walter T Ambrosius, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|June 3, 2024
Adult obesity treatment and prevention: A trans-agency commentary on the research landscape, gaps, and future opportunitiesRebecca K Hoffman, Laurie Friedman Donze, Tanya Agurs-Collins, et al.
Childhood Obesity (Print)|September 16, 2020
Childhood Obesity Evidence Base Project: A Systematic Review and Meta-Analysis of a New Taxonomy of Intervention Components to Improve Weight Status in Children 2-5 Years of Age, 2005-2019Lori A J Scott-Sheldon, Larry V Hedges, Chris Cyr, et al.
Childhood Obesity (Print)|September 16, 2020
Childhood Obesity Evidence Base Project: Methods for Taxonomy Development for Application in Taxonomic Meta-AnalysisHeather King, Mackenzie Magnus, Larry V Hedges, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Journal of Immunology (Baltimore, Md. : 1950)|January 11, 2012
IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J miceAndrew L Rankin, Heath Guay, Deborah Herber, et al.
Science Translational Medicine|December 21, 2012
Long-term follow-up after gene therapy for canavan diseasePaola Leone, David Shera, Scott W J McPhee, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Interleukin-21 receptor deficiency increases the initial toll-like receptor 2 response but protects against joint pathology by reducing Th1 and Th17 cells during streptococcal cell wall arthritisRenoud J Marijnissen, Debbie M Roeleveld, Deborah Young, et al.
Diabetes|October 21, 2011
IL-21 is an antitolerogenic cytokine of the late-phase alloimmune responseAlessandra Petrelli, Michele Carvello, Andrea Vergani, et al.
The Journal of Clinical Investigation|December 17, 2008
IL-21R is essential for epicutaneous sensitization and allergic skin inflammation in humans and miceHaoli Jin, Michiko K Oyoshi, Yi Le, et al.
Platelets|March 10, 2017
Inhibition of NMDA receptor function with an anti-GluN1-S2 antibody impairs human platelet function and thrombosisTaryn N Green, Justin R Hamilton, Marie-Christine Morel-Kopp, et al.
Journal of Clinical Epidemiology|March 4, 2019
The selection of comparators for randomized controlled trials of health-related behavioral interventions: recommendations of an NIH expert panelKenneth E Freedland, Abby C King, Walter T Ambrosius, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|June 3, 2024
Adult obesity treatment and prevention: A trans-agency commentary on the research landscape, gaps, and future opportunitiesRebecca K Hoffman, Laurie Friedman Donze, Tanya Agurs-Collins, et al.
Childhood Obesity (Print)|September 16, 2020
Childhood Obesity Evidence Base Project: A Systematic Review and Meta-Analysis of a New Taxonomy of Intervention Components to Improve Weight Status in Children 2-5 Years of Age, 2005-2019Lori A J Scott-Sheldon, Larry V Hedges, Chris Cyr, et al.
Childhood Obesity (Print)|September 16, 2020
Childhood Obesity Evidence Base Project: Methods for Taxonomy Development for Application in Taxonomic Meta-AnalysisHeather King, Mackenzie Magnus, Larry V Hedges, et al.
Pageof 11